부산대학교 도서관

Strosberg JR; Moffitt Cancer Center, Tampa, FL, USA. Electronic address: jonathan.strosberg@moffitt.org.; Caplin ME; Royal Free Hospital, London, UK.; Kunz PL; Yale School of Medicine, New Haven, CT, USA.; Ruszniewski PB; Division of Gastroenterology and Pancreatology, Université de Paris and Beaujon Hospital, AP-HP, Clichy, France.; Bodei L; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Hendifar A; Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Mittra E; Division of Diagnostic Radiology, Oregon Health and Science University, Portland, OR, USA.; Wolin EM; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Yao JC; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pavel ME; Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany.; Grande E; MD Anderson Cancer Center Madrid, Madrid, Spain.; Van Cutsem E; Division of Digestive Oncology, University of Leuven, University Hospital Gasthuisberg, Leuven, Belgium.; Seregni E; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Duarte H; Portuguese Institute of Oncology, Porto, Portugal.; Gericke G; Novartis Pharma AG, Basel, Switzerland.; Bartalotta A; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.; Mariani MF; Novartis Pharma AG, Basel, Switzerland.; Demange A; Novartis Pharma AG, Basel, Switzerland.; Mutevelic S; Novartis Pharma AG, Basel, Switzerland.; Krenning EP; Department of Nuclear Medicine, Erasmus Medical Center, Rotterdam, Netherlands.

Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Grenader T; Oncology Institute, Leumit Health Services, Jerusalem, Israel.; Pavel ME; Medizinische Klinik m. S. Hepatologie und Gastroenterologie, Charité University Medicine Berlin, Berlin, Germany.; Department of Endocrinology, Friedrich Alexander University Erlangen-Nuernberg, Erlangen, Germany.; Ruszniewski PB; Department of Gastroenterology-Pancreatology, Beaujon Hospital, Clichy, France.; Ćwikła JB; Department of Radiology, University of Varmia and Masuria, Olsztyn, Poland.; Phan AT; Hematology, Oncology & Radiation Oncology, University of Texas Health Science Center at Tyler, Tyler, Texas, USA.; Raderer M; Department of Oncology, University Hospital, Vienna, Austria.; Sedláčková E; Department of Oncology, First Faculty of Medicine and General Teaching Hospital, Prague, Czech Republic.; Cadiot G; Hepato-Gastroenterology & Digestive Cancerology, Robert-Debré Hospital, Reims, France.; Wolin EM; Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Capdevila J; Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Wall L; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK.; Rindi G; Pathological Anatomy, Fondazione Policlinico Universitario A. Gemelli IRCCS - Università Cattolica del Sacro Cuore, Rome, Italy.; Truong Thanh XM; Medical Affairs, Ipsen, Boulogne-Billancourt, France.; Caplin ME; Gastroenterology and Neuroendocrine Tumours, Royal Free Hospital, London, UK.

Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE

Strosberg JR; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany Jonathan.Strosberg@moffitt.org.; Yao JC; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.; Bajetta E; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.; Aout M; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.; Bakker B; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.; Hainsworth JD; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.; Ruszniewski PB; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.; Van Cutsem E; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.; Öberg K; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.; Pavel ME; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.

Publisher: BioScientifica Country of Publication: England NLM ID: 9436481 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1479-6821 (Electronic) Linking ISSN: 13510088 NLM ISO Abbreviation: Endocr Relat Cancer Subsets: MEDLINE